Geron (GERN)
(Delayed Data from NSDQ)
$4.57 USD
-0.21 (-4.39%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $4.58 +0.01 (0.22%) 7:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
GERN 4.57 -0.21(-4.39%)
Will GERN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GERN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GERN
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Geron (GERN) to Report Q2 Earnings: What's in the Cards?
GERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
Other News for GERN
Geron: Probabilistic And Modest Estimate Of Pricing For A Likely Acquisition
Geron stock gains 6% on updated guidelines for Rytelo
Geron Announces Updated NCCN Guidelines? Recommending RYTELO? (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS
Geron announces updated NCCN guidelines recommending Rytelo
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session